NEW TREATMENT FOR BRCA-MUTATED METASTATIC BREAST CANCER

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
来源：
AMERICAN JOURNAL OF NURSING | 2018年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：21 / 23
页数：4
相关论文
共 50 条
  • [21] Development of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of BRCA-Mutated Breast Cancer
    Sulai, Nanna H.
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (07) : 491 - 501
  • [22] Maintenance olaparib in Asian patients with germline BRCA-mutated metastatic pancreatic cancer
    Oh, Do-Youn
    Park, Joon Oh
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Arnold, Dirk
    Reinacker-Schick, Anke
    Tortora, Giampaolo
    Algul, Hana
    O'Reilly, Eileen M.
    McGuiness, David
    Liu, Yu-Zhen
    Cui, Karen
    Schlienger, Katia
    Locker, Gershon Y.
    Golan, Talia
    ANNALS OF ONCOLOGY, 2021, 32 : S319 - S319
  • [23] Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Li, Na
    Zheng, Huanrui
    Huang, Yanlei
    Zheng, Bin
    Cai, Hongfu
    Liu, Maobai
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Olaparib for BRCA-mutated advanced ovarian cancer
    de Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (06): : 206 - 208
  • [25] Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic Approaches
    Dilmac, Sayra
    Ozpolat, Bulent
    CANCERS, 2023, 15 (14)
  • [26] BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
    Marciano, Naomie Devico
    Kroening, Gianna
    Dayyani, Farshid
    Zell, Jason A.
    Lee, Fa-Chyi
    Cho, May
    Valerin, Jennifer Goldstein
    CANCERS, 2022, 14 (10)
  • [27] PARP inhibition in BRCA-mutated breast and ovarian cancers
    Chan, Stephen L.
    Mok, Tony
    LANCET, 2010, 376 (9737): : 211 - 213
  • [28] PARP inhibitor treatment of advanced breast cancer beyond the BRCA-mutated type: a meta-analysis
    Yan, Feifei
    Jiang, Qi
    He, Mengye
    Shen, Peng
    FUTURE ONCOLOGY, 2021, 17 (18) : 2381 - 2393
  • [29] Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Wu, Bin
    Shi, Lizheng
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11): : 1528 - +
  • [30] Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
    Cruz, Cristina
    Llop-Guevara, Alba
    Garber, Judy E.
    Arun, Banu K.
    Perez Fidalgo, Jose A.
    Lluch, Ana
    Telli, Melinda L.
    Fernandez, Cristian
    Kahatt, Carmen
    Galmarini, Carlos M.
    Soto-Matos, Arturo
    Alfaro, Vicente
    Perez de la Haza, Aitor
    Domchek, Susan M.
    Antolin, Silvia
    Vahdat, Linda
    Tung, Nadine M.
    Lopez, Rafael
    Arribas, Joaquin
    Vivancos, Ana
    Baselga, Jose
    Serra, Violeta
    Balmana, Judith
    Isakoff, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3134 - +
12345